Figure 9.The performance of 6-gene signature under different clinical characteristics. KM survival curves for the two risk subgroups of LUSC patients stratified by age (A, B) and tumor stage (C, D).
Figure 9 — Characterization of platelet-related genes and constructing signature combined with immune-related genes for predicting outcomes and immunotherapy response in lung squamous cell carcinoma | Aging
